vTv Therapeutics
vtvtherapeutics.com
Biotechnology
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
HIGH POINT, N.C., Sept. 15, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the...
Read more
Report
vTv Therapeutics Inc. (NASDAQ:VTVT) Just Beat Earnings: Here
A week ago, vTv Therapeutics Inc. ( NASDAQ:VTVT ) came out with a strong set of quarterly numbers that could...
Read more
Report
Vtv Therapeutics: Capital Efficiency and Clinical Catalysts Under Scrutiny
Analysis of Vtv Therapeutics
Read more
Report
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737
vTv Therapeutics Inc. (NASDAQ:VTVT) is one of the most promising micro-cap stocks according to analysts. On February 2, vTv Therapeutics expanded its partnership with Newsoara Biopharma Co. Ltd., transforming a regional agreement into a global collaborati
Read more
Report
VTv Therapeutics Names Michael Tung CFO, Effective Immediately
(RTTNews) - vTv Therapeutics Inc. (VTVT), a late-stage biopharmaceutical company, announced Monday the appointment of Michael Tung as Executive Vice President and Chief Financial Officer, effective immediately.
Read more
Report
Report
vTv Therapeutics Announces Resumption of CATT1 Phase 3 Trial for Cadisegliatin as Potential First Oral Adjunct Therapy for Type 1 Diabetes
vTv Therapeutics resumes CATT1 Phase 3 trial for cadisegliatin, an oral adjunct therapy for type 1 diabetes, after FDA lifts hold.
Read more
Report
Some of the Social Determinants of helth
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text
Read more
Report
Outdoor Blood Bank Stand Frozen Plasma
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text
Read more
Report
Show more news
People
Rudy Howard
Executive Officer
Stephen Holcombe
Executive Officer
Larry Altstiel
Executive Officer
Jeffrey Kindler
Director
Steven Tuch
Executive Officer
Richard Nelson
Executive Officer, Director
Paul Sekhri
Executive Officer, Director
Paul Meister
Director
Paul Savas
Director
Noel Spiegel
Director
Howard Weiner
Director
John Fry
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
High Point
United States
HQ
50-200 est. staff
Financials
Total raised
$68.5M
Latest round
Venture - Series Unknown
Funding rounds
5